Hope for high risk chronic lymphocytic leukemia after ibrutinib failure

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	S620-S623
Journal	Translational Cancer Research
Volume	7
DOIs	https://doi.org/10.21037/tcr.2018.05.35
State	Published - 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{6c679945e6714143a2a1532dad195d68,

title = "Hope for high risk chronic lymphocytic leukemia after ibrutinib failure",

author = "Ohad Benjamini",

year = "2018",

doi = "10.21037/tcr.2018.05.35",

language = "אנגלית",

volume = "7",

pages = "S620--S623",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Hope for high risk chronic lymphocytic leukemia after ibrutinib failure

AU - Benjamini, Ohad

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/pages/publications/85048239581

U2 - 10.21037/tcr.2018.05.35

DO - 10.21037/tcr.2018.05.35

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

AN - SCOPUS:85048239581

SN - 2218-676X

VL - 7

SP - S620-S623

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -